Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Mar 05 2026

· Issued by Dr. Lalchandani Labs Ltd. via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/dr-lalchandani-labs-ltd-press-release-mar-05-2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuraag Gambhir

View Attachment

6ix hasn’t read this filing yet.

Dr. Lalchandani Labs Ltd. on 6ix

Earlier from Dr. Lalchandani Labs

Later from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases